Internal restructuring
Location of affected unit(s)
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

2,800 jobs
Number of planned job losses
Job loss
Announcement Date
18 January 2012
Employment effect (start)
18 January 2012
Foreseen end date
31 December 2015


Takeda Pharmaceuticals is to reduce its global workforce by 10% with the loss of the jobs of 2,100 European employees and 700 US-employees. Most of these jobs will be lost in R&D, commercial, operations and General & Administrative sections.

Within Europe, the German operations of Takeda face a sweeping reorganisation. However, Takeda did not give any other details on the job losses in Europe, apart from stressing that in many countries an overlap exists between the activities of the company and those of Nycomed, the company that Takeda acquired recently.

The internal restructuring process should be fully implemented by the end of 2015.


  • 18 January 2012: Financial Times


Eurofound (2012), Takeda Pharmaceuticals, Internal restructuring in World, factsheet number 72982, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/72982.